Browse All

Current Filters

CLEAR FILTER x

TITLE

A Novel FA2H Variant with Cerebellar Hypometabolism: A Case Report of Suspected SPG35

Author:Talavera De la Esperanza, Blanca   Chinchihualpa Paredes, Nathaly   herrera, andrea   Collins-Ruff, Kathleen   Yu, Zheming   Lin, Amanda   Patino Murillas, Jorge   Espay, Alberto   Marsili, Luca   

Session Name:P4: Movement Disorders: Ataxias 1  

Topic:Movement Disorders  

Program Number:P4.010  

Author Institution:University of Cincinnati, Cincinnati, OH  University of Cincinnati, OH  University of Cincinnati Medical Center, Cincinnati, OH  

Response Trajectories of Patients with Parkinson’s Disease Psychosis Treated with Pimavanserin: An Exploratory Cluster Analysis

Author:Dashtipour, Khashayar   Espay, Alberto   Zhang, Peter   Abler, Victor   Brunson, Greg   Chrones, Lambros   

Session Name:P11: Aging, Dementia, and Behavioral Neurology: Synucleinopathies  

Topic:Aging, Dementia, and Behavioral Neurology  

Program Number:P11.006  

Author Institution:Department of Neurology, Loma Linda University School of Medicine, Loma Linda, CA  University of Cincinnati Gardner Neuroscience Institute, Gardner Family Center for Parkinson’s Disease and Movement Disorders, Department of Neurology, University of Cincinnati, Cincinnati, OH  Acadia Pharmaceuticals, Inc., North Potomac, MD  Acadia Pharmaceuticals, Inc., Cincinnati, OH  Acadia Pharmaceuticals, Inc., San Clemente, CA  Acadia Pharmaceuticals, Inc., Westmont, IL